Moderna Inc.
-
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read MoreNov 4, 2022
-
VUMC-led study finds Moderna COVID vaccine safe and effective for children
Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by C. Buddy Creech, MD, MPH, has found. Read MoreMay 12, 2022
-
VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial. Read MoreJul 14, 2020